CO65 Real-world Impact of Semaglutide, Liraglutide, and Tirzepatide on Weight Loss and Cardiometabolic Lab Measures: A Look into Drug Persistence and Reasons for Discontinuation (r/dc)
Jul 1, 2025, 00:00
10.1016/j.jval.2025.04.150
https://www.valueinhealthjournal.com/article/S1098-3015(25)00274-8/fulltext
Title :
CO65 Real-world Impact of Semaglutide, Liraglutide, and Tirzepatide on Weight Loss and Cardiometabolic Lab Measures: A Look into Drug Persistence and Reasons for Discontinuation (r/dc)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)00274-8&doi=10.1016/j.jval.2025.04.150
First page :
Section Title :
Open access? :
No
Section Order :
11167